Investigating the link between PFAS exposure and cancer risk in children
Exposure to per- and polyfluoroalkyl substances (PFAS) and risk of cancer in children
This study is looking at how certain chemicals called PFAS, which can be found in things like drinking water and household dust, might affect the risk of cancer in children, and it aims to help us understand the health impacts on kids during important stages of their growth.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10678857 on NIH RePORTER |
What this research studies
This research focuses on understanding how exposure to per- and polyfluoroalkyl substances (PFAS) affects the risk of developing cancer in children. The study will analyze various exposure routes, including drinking water, blood samples from newborns and pregnant women, and household dust. By examining these factors during critical developmental periods, the research aims to provide insights into the potential health impacts of PFAS on young populations. The project involves collaboration among experts in pediatric epidemiology and environmental health to ensure a comprehensive approach.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and pregnant women living in areas with known PFAS contamination.
Not a fit: Patients who do not live in PFAS-contaminated areas or who are not within the age range of 0-21 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and prevention strategies for childhood cancers linked to PFAS exposure.
How similar studies have performed: While there have been reports of childhood cancer clusters in PFAS-affected areas, this research is among the first to systematically assess the cancer risk in children due to PFAS exposure.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Metayer, Catherine — University of California Berkeley
- Study coordinator: Metayer, Catherine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.